{
 "@context" : "http://schema.org",
  "id" : "http://bio2rdf.org/drugbank:DB00095",
  "type" : "Drug",
  "alternateName" : "antiCD11 alpha",
  "description" : "Humanized IgG1 kappa isotype monoclonal antibody that binds to human CD11a. Efalizumab has a molecular weight of approximately 150 kilodaltons and is produced in a Chinese hamster ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin.",
  "legalStatus" : "approved",
  "mechanismOfAction" : "Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes. As a result efalizumab decreases cell surface expression of CD11a.",
  "name" : "Efalizumab",
  "schema:sameAs" : "https://www.drugbank.ca/drugs/DB00095",
  "schema:url" : "https://www.drugbank.ca/drugs/DB00095"
}